Using a computer-generated sequence , we randomly allocated eligible patients-those aged @-@ years with relapsing-remitting multiple sclerosis-to receive fingolimod @ mg , fingolimod @ mg , or placebo orally once daily ( @:@:@ ; stratified by study centre ) .